Fluphenazine Hydrochloride
Fluphenazine Hydrochloride is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Fluphenazine Hydrochloride; Generic name: FLUPHENAZINE HYDROCHLORIDE; Manufacturer: PAI Holdings, LLC dba PAI Pharma.
| Brand name | Fluphenazine Hydrochloride |
|---|---|
| Generic name | FLUPHENAZINE HYDROCHLORIDE |
| Manufacturer | PAI Holdings, LLC dba PAI Pharma |
| Used for | INDICATIONS AND USAGE Fluphenazine hydrochloride is indicated in the management of manifestations of psychotic disorders. Fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation. |
| Dosage | DOSAGE AND ADMINISTRATION Depending on the severity and duration of symptoms, total daily dosage for adult psychotic patients may range initially from 2.5 to 10 mg and should be divided and given at six- to eight- hour intervals. The smallest amount that will produce the desired results must be carefully determined for each individual, since optimal dosage levels of this potent drug may vary from patient to patient. In general, the oral dose has been found to be approximately two to three times |
| Warnings | WARNINGS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Fluphenazine Hydrochloride Oral Solution USP (Concentrate) is not approved for the treatment of patients with dementia-related psychosis ( see BOXED WARNING ). Tardive Dyskinesia Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements may develop in pat |
| Active ingredient(s) | FLUPHENAZINE HYDROCHLORIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0860b3f3-3116-40f8-bcb0-e5c47731bdc8 |